INTRODUCTION
The sera of patients with systemic lupus erythematosus (SLE)' characteristically contain antibodies reactive with a variety of plasma, cellular, and subcellular constituents. Among these, autoantibodies to nuclear antigens have been the most extensively studied, and DNA:
anti-DNA complexes have been implicated in the development of the renal and vascular lesions of this ',Abbreviations used in this paper: ANA, antinuclear antibody; CF, complement fixation; EA, sensitized sheep red cells; E: S, enzyme: substrate; RA, rheumatoid arthritis; RF, rheumatoid factor; SLE, systemic lupus erythematosus; SN, supernate; VBS, Veronal-buffered saline.
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disease (2) (3) (4) (5) (6) . Antibodies to several types of cytoplasmic antigens have also been described (7) (8) (9) (10) (11) (12) (13) (14) (15) but their pathogenetic importance in SLE is less clear.
Previous studies on the occurrence of antibodies to lysosomes in SLE were based upon complement fixation (CF) reactions with relatively crude cytoplasmic fractions derived to a large extent from nonhuman tissues (10, 16) . The present investigation was designed to reexamine the question of antibodies to lysosomes in SLE, with particular respect to: (a) immune reactivity of SLE sera with extensively characterized preparations of human lysosomes by both CF and immunodiffusion techniques; and (b) the possible presence of lysosomal antigen(s) in the sera or pathologic fluids of SLE patients. For comparison, similar studies were also undertaken in patients with other rheumatic or immunologic disorders.
METHODS

Preparation and characterization of antigens
Lysosome granules were prepared from the peripheral blood leukocytes of several normal group 0 donors by a slight modification of the method of Chodirker, Bock, and Vaughan (17) . 100 ml of freshly drawn venous blood was immediately diluted in 1,900 ml of cold isotonic saline containing 0.1% bovine serum albumin and subjected to cold centrifugation in 250-ml glass centrifuge bottles (800 g, 30 min) to recover the cells. After three cycles of hypotonic saline lysis of red cells, the remaining leukocytes were recovered by cold centrifugation (110 g, 5 min) and then washed successively in cold isotonic saline and 0.34 M sucrose. The washed leukocytes were lysed in 0.2 M sucrose containing 3.6 mg (500 U) per ml of heparin (17) . Overnight cold incubation (40C) of leukocyte lysates was followed by low-speed centrifugation (800 g, 15 min) to remove cell debris and this was followed by centrifugation (25,000 g, 10 min) at 4VC to sediment the lysosome granules. The granules were resuspended in 0.34 M sucrose (containing 250 U of heparin per ml), washed in heparinfree 0.34 M sucrose, then cleared of lysosomal clumps (centrifugation at 600 g, 10 min) before use. All centrifugations were carried out in refrigerated centrifuges (PR 2, International Equipment Co., Needham Heights, Mass.; RC 2B, Ivan Sorvall, Inc., Newtown, Conn.; L-240, Beckman Instruments, Inc., Spinco Div., Palo Alto, Calif.).
The final yield of lysosome granules in, such preparations was 3-4 ml of a suspension containing approximately 1 mg protein/ml by Folin analysis using an egg albumin standard (18) . The preparations were promptly examined by phase-contrast microscopy (1,000 X) and typically showed a myriad of granules dancing freely in Brownian movement. Granule preparations were discarded if they contained recognizable red cells, leukocytes or platelets, or more than occasional cell debris or granule clumps. As a further test of lysosomal purity, electron micrographs of two representative preparations were kindly prepared by Dr. Goetz W. Richter, Department of Pathology, University of Rochester. Lysosomal granules were sedimented (25,000 g, 10 min), fixed with 2% gluteraldehyde (3 h) and 1% 0304 (1 h) , and stained with uranyl acetate (20 min) and lead citrate (5 min). These electron micrographs ( Fig. 1) revealed that virtually all of the particles possessed typical morphologic features of lysosomes Recognizable cells were not observed. Occasional fragments of cell membrane or of other subcellular organelles were found in some fields.
Acid phosphatase, myeloperoxidase, and neutral protease activities were readily detectable in fresh preparations of lysosomes but were greatly increased by disruption of the granules with 0.1% Triton X-100. Acid phosphatase was measured as described by Janoff, Weissman, Zweifach, and Thomas (19) (20) . Neutral protease activity was assayed by digestion of denatured hemoglobin (21, 22) but in a pH 7.3 phosphate-buffered saline system instead of acid buffer. p-Glucuronidase was also measured in such lysosome preparations when the method of isolation was being developed (17) . Succinic dehydrogenase (23) and reduced NAD dehydrogenase (cytochrome c reductase) (24) activities were not detected in the current lysosome preparations.
(Na+, K+)-ATPase activity was measured in lysosome membranes as a test for contamination by fragments of leukocyte plasma membrane (25) . This Lysosomes were also obtained by an alternative protocol obtained from Dr. Robert I. Lehrer, University of California. Briefly, heparinized blood was subjected to (a) low-speed centrifugation to remove platelets and plasma; (b) centrifugation at 400 g in a Ficoll-34%o Hypaque gradient, yielding a mononuclear layer (discarded) and a granulocyte-red cell pellet; (c) sedimentation of the latter fraction in 3% dextran followed by hypotonic lysis to remove red cells; (d) resuspension of granulocytes in 0.34 M sucrose and homogenization in a glass-Teflon homogenizer; (e) washes in 0.34 M sucrose to remove debris and final recovery of lysosomes by centrifugation in cellulose nitrate tubes in a Spinco model L ultracentrifuge (SW-50 rotor) for 20 min at 27,000 rpm. The yield of lysosomes in our hands was comparable to that in our standard procedure. The second method was selected because it avoids exposure of subcellular structures to high concentrations of heparin, which has been shown to release DNA and RNA from rat liver nuclei (27 
Detection of antilysosome antibodies
Quantitative CF tests were patterned after the method of Wassermann and Levine (34) . Sensitized sheep red cells (EA), 5 X 101 cells/ml, in isotonic Veronal-buffered saline (VBS) containing Ca+ and Mg" were prepared as previously described (35) . Only freshly prepared lysosomes, stored no more than 3 days at 5'C, were used for these assays. Into 10-ml tubes in an ice bath were placed 0.5 ml diluent (see below), 0.25 ml diluted test serum, 0.25 ml reconstituted lyophilized guinea pig serum containing 10 CHra U/ml, and, lastly, 0.5 ml lysosomes diluted in 0.34 M sucrose, typically to S or 25 *g/ml. Antigen (lysosome), antibody (serum), and complement control tubes were run in duplicate in each experiment The tubes were incubated at 4VC for 18-20 h, then chilled in ice, and 0.25 ml of EA were added to each tube. Incubation then proceeded at 370C until the complement controls indicated 100%o lysis. The tubes were centrifuged and the ODn nm of each supernate was measured spectrophotometrically. The final percent of CF was calculated after subtracting the sum of any complement consumption occurring in the antigen (lysosome) control and serum control. In practice this total correction seldom exceeded 4-5%, owing to the pretreatment described Lysosomal Protein-pg/ml failed to give at least 10% corrected CF at any dilution were listed as negative in Table I . With each CF assay of unknown sera one or more known positive SLE sera and the rabbit antilysosome serum were included as positive controls. Successful development of the above CF system depended upon overcoming substantial anticomplementary activity of the lysosomes themselves and of many SLE sera. The anticomplementary effect of lysosomes was circumvented by incorporating additional "carrier" protein in the system, i.e., the diluent was VBS containing 1:12 heat-inactivated normal human serum. Before CF assays, SLE sera were pretreated as follows: 3 ml 1:10 serum (in VBS) was incubated with 70 CH.o U of guinea pig complement at 370C for 60 min and then inactivated at 560C for 30 min. This procedure' markedly reduced anticomplementary activity of SLE sera but did not hinder positive CF reactions with lysosomes. For uniformity, all human sera to be tested, including normals, were pretreated in this manner.
Fractionation of 1-ml aliquots of selected SLE sera was performed at 5°C in a 2.5 X 90-cm Sephadex G-200 column in borate-saline buffer, pH 8.0, with a flow rate of 8 ml/h. IgG-, IgA-, IgM-, and albumin-rich fractions were determined by immunodiffusion against specific antisera. Representative fractions were tested in CF assays against lysosomes (see below).
Precipitin analysis in gel. Tests for precipitating antibody against various antigens were made by double diffusion in glass petri dishes containing 25 ml freshly prepared 0.4% agarose gel in phosphate-buffered saline, pH 7.3, producing a gel thickness of 5 mm. Wells were 8 mm in diameter and placed 4 mm apart. When 1 All values represent percent CF after correction for anticomplementary effects of lysosomes alone and of serum alone. § NT, not tested.
Seven of the 14 patients were tested. ¶ Drug-SLE, drug-induced "lupus" syndrome; AHA, autoimmune hemolytic anemia. ** Miscellaneous rheumatic disorders including Wegener's granulomatosis (two cases), polymyalgia rheumatica (two), Henoch-Sch6nlein purpura (one), chronic glomerulonephritis (one), and viral hepatitis with polyarthritis (one).
were used as antigen, the well was completely filled at least 6 h ahead of the serum wells and then refilled at the time of addition of serum. Lysosomes were used at a concentration of 1,000-1,500 ,ug/ml. Diffusion occurred during 24-48 h at room temperature.
Patients Sera from patients had been stored at -20'C before study. Pleural and joint fluids were examined, however, as fresh specimens. SLE cases were selected only on the basis that clinical and laboratory evidence clearly supported the diagnosis and that sufficient serum was available for study. Some of these patients had more limited forms of SLE such as thrombocytopenic purpura with positive LE cell test and antinuclear antibody (ANA), or Coombspositive hemolytic anemia associated with strongly positive ANA, joint symptoms, and Raynaud's phenomenon. The rheumatoid arthritis (RA) patients included had definite or classical RA. The procaine amide-induced lupus patients exhibited diagnostic features previously described (36 (1/100,000). After fractionation of the serum on Sephadex G-200, proteins eluting in the first peak were concentrated and passed through another Sephadex G-200 column under acid-dissociating conditions. The first peak contained potent IgMK RF exhibiting monoclonal properties in polyacrylamide gel electrophoresis and isoelectric focusing.
In SLE patients antibodies to native or single-strand DNA were measured by a Farr-type radioimmunoassay as described (37) (Fig. 2) , and with SLE serum dilutions in the 1: 40 to 1: 2,560 range (Table I) . Among the 37 SLE patients tested, serum from at least one date of bleeding in 23 patients (62%) gave positive CF reactions (Table I) . CF reactions were negative at all dilutions tested with sera from 14 normal donors, 10 patients with drug-induced lupus syndrome (due to procaine amide in nine, hydralazine in one), 15 patients with RA (12 seropositive, three seronegative), four patients with polymyositis, 26 patients with autoimmune hemolytic anemia (not associated with SLE), and a small group of miscellaneous rheumatic disorders (Table I, Fig. 2 ). Two cases of chronic active ("lupoid") hepatitis with positive ANA gave moderately positive CF reactions with lysosomes (Table I) .
Rabbit antilysosome serum produced CF at comparable lysosome and serum concentrations. Lysosomes from six different group 0 donors gave positive CF reactions of generally similar strength with either rabbit or SLE sera. Entirely comparable CF reactions were obtained with lysosomes prepared by the alternate procedure (see Methods). By gel filtration on Sephadex G-200 the antilysosomal CF activity of two SLE sera eluted with IgG globulins (Fig. 3) .
The theoretical possibility arose that the presence of RF in certain SLE or RA sera might interfere with Table I ). Control aliquots received buffer alone. Latex titers were raised to 1/5,120 in both RF-treated sera but there was no change in CF reactions at any serum dilution, compared to the controls.
Gel precipitin reactions. Seven of 21 SLE sera examined by immunodiffusion against lysosome preparations demonstrated a single precipitin arc close to the antigen well (Table I ). This reaction is illustrated in Fig. 4 by serum Kli. A precipitin line against lysosome granules is clearly visible with undiluted serum and faintly with 1: 4 serum. The precipitin line between lysosomes and SLE serum Kli. was closer to the antigen FIGURE 4 Immunodiffusion analysis (0.4% agarose) of SLE sera and rabbit antilysosome serum against human leukocyte lysosomes, 1.5 mg protein/ml (center well (lysosome) well than the much stronger precipitin line(s) obtained with rabbit antilysosome serum (Fig.  4) , suggesting that different antigenic components are detected by the SLE and rabbit immune sera by this method. SLE serum Tay. (9/68 bleeding) shows no reaction (Fig. 4) , but an earlier pretreatment serum was clearly positive (see Table IV , below). Only those SLE sera exhibiting the strongest CF reactions also showed gel precipitin reactions with lysosomes (Table   I ). The faint precipitin lines between the rabbit antiserum and the SLE sera (arrows, Fig. 4 ) are discussed below.
Characterization of reactive lysosomal components. Multiple aliquots of lysosomes (25 ug/ml) were centrifuged at 12,330-40,000 g for variable periods of time. Supernates and uncentrifuged lysosomes were compared in CF reactions with four SLE sera representing strong, moderate, and weak CF reactivity. As shown in Table   II , a major loss of the original CF antigenic activity of the lysosomes with SLE sera was observed after centrifugation at 40,000 g for 3 h. Smaller losses of antigenic activity were observed with shorter or slower centrifugations (serums Tay. and Kli.).
Lysosomes at concentrations of 850 usg/ml or more (> 150 times the concentration capable of giving CF reactions with SLE serum) gave no reaction in the diphenylamine assay for DNA. This indicates that < 5 ,ug/ml of DNA is present in a typical undiluted lysosome preparation and < 0.15 og/ml in the dilute lysosome suspensions (25 ug/ml) which gave optimal CF reactions. Similarly, in two lysosome preparations containing 1,170 and 550 ug protein/ml, respectively, the measured (29) RNA content was 20 ug/ml. This implies an RNA content of 0.017-0.036 ,ug/ml when such lysosome preparations are diluted (25 ,ug/ml) for CF assays.
Furthermore, as shown in Table III , the capacity to react in CF assays with SLE sera was not affected by prior treatment of the lysosomes with high concentrations of DNase or RNase sufficient to cleave nearly all of the added radioactive DNA or RNA serving as monitors of nuclease activity. Fig. 5 shows the results of gel precipitin reactions of lysosomes and DNA with two different SLE sera, one of which (Tay., well 4) reacts with both DNA (well 3) and lysosomes (well 1). After extensive absorption with DNA, serum Tay. (well 5) no longer reacts with DNA (well 6) but reacts just as strongly with lysosomes. The second patient's serum(Mend., well 2) gives no visible reaction with DNA (well 3) but forms a precipitin arc with lysosomes which fuses with that given by serum Tay. The precipitin line between wells 4 and 5 is attributable to excess DNA in the absorbed Tay. serum (well 5). In other studies (not shown) lysosomes and DNA, which had been incubated in parallel with DNase, were tested by immunodiffusion against SLE sera known to give precipitin reactions with both DNA and lysosomes. This treatment abolished the reactions of DNA with these SLE sera but did not affect the reactivity of lysosomes. Similarly, treatment of lysosomes with RNase had no effect on their precipitin reactions with SLE sera. SLE serum Mor. gave gel precipitin lines against both lysosomes and a partially purified preparation of the nuclear antigen, Sm (30) . These appeared to be reactions of nonidentity but this was not conclusive because of marked differences in the diffusion rates of these two antigens. Exhaustive absorption of Mor. serum with the Sm antigen, however, abolished precipitin reactivity with Sm but not with lysosomes, indicating that the precipitin reaction with lysosomes is not attributable to the Sm: anti-Sm system. Clinical correlations. Table IV summarizes retrospective clinical data on a small group of SLE patients on whom the availability of multiple serum samples permitted serial measurements of antilysosome antibody.
In these cases potent antibody, as defined by CF titers greater than 2,560 and positive precipitin reactions, was found during periods of active disease prior to corticosteroid therapy or in association with a clinical relapse after steroids had been discontinued (patient Mem.). Among the other SLE patients, tested at a single point in time, many with negative or very low FIGuRE Detection of lysosomal antigen in serum and other body fluids A faint but reproducible precipitin line (arrows, Fig.  4 ) is visible between rabbit antilysosome serum (wells 3 and 6) and the two SLE sera (wells 4 and 5). A similar precipitin line with the rabbit antiserum was also observed with 10 of 17 other SLE sera, suggesting the possible presence of lysosomal antigen in these sera. Further studies established that such precipitin reactions (a) were not observed with normal human sera; (b) were not altered by heating the SLE serum to 560C for 30 min; (c) occurred with the 40 % ammonium sulfate fraction of the rabbit antiserum, but not with preimmune serum from the same animal nor with rabbit antisera to human gamma globulin or to denatured DNA; (d) were not affected by absorption of the rabbit antiserum with pooled normal human serum; and (e) were not observed when rabbit antilysosome serum was diffused against DNA (native and denatured), soluble nucleoprotein, Sm antigen, or human immunoglobulins, all tested at concentrations similar to that of the lysosomes.
Studies were initiated to clarify the relationship of this antigenic component in SLE sera with lysosomes isolated from normal donors. Lysosomes (1.5 mg/ml) prepared by the standard procedure were divided into two equal aliquots. One was subjected to 10 freeze-thaw cycles; the other (control) aliquot was maintained at 370C.
Both preparations were centrifuged at 31,000 g (30 min) and the upper 2/3 supernate (SN) was carefully aspirated. Immunodiffusion analysis (Fig. 6) revealed that a component antigenically identical to a component in the whole ("intact") lysosomes6 was released into the granule SN by freezing and thawing. This was not detectable in the control SN. In Fig. 7 the fusion of the precipitin lines given by the freeze-thaw granule SN and by the lysosomal antigen in the SLE serum indicates their close antigenic relationship. After chromatography on Sephadex G-200 this antigenic activity of the granule SN was identified in the included volume only and was not detectably depleted after centrifugation at 130,000 g for 4 h, suggesting that a soluble antigen was involved. The same freeze-thaw granule SN, however, showed no precipitin reactivity with three SLE sera which had given precipitin reactions with intact lysosomes. As shown in Table V , even with the sensitive CF assay there was no reaction between this freezethaw SN and a known CF-positive SLE serum; the rabbit antiserum, however, produced a clearly positive reaction, somewhat weaker than with whole lysosomes. These data provide further evidence that the rabbit antiserum and SLE sera react with different lysosomal constituents.
Lysosomal antigen in various clinical disorders. The rabbit antilysosome serum was tested (in 0.4% agarose) against sera and other extracellular fluids from patients with various clinical disorders and the results are summarized in Table VI . When present, these precipitin lines always gave reactions of identity with each other (i.e., from one fluid to another or from case to case) and with whole lysosome preparations. Another patient not included in Table VI had a transient leukemoid reaction and myalgic syndrome of undetermined etiology. When sera were studied serially, lysosomal antigen could be detected only while there was a significant granulocytosis. In another patient, with SLE, lysosomal antigen appeared during some periods of active disease but could not be correlated with the level of granulocytosis.
DISCUSSION
This study demonstrates that a significant number of patients with active SLE display CF and gel precipitin reactions with a sedimentable component of lysosome preparations derived from normal human leukocytes. In view of the wide array of autoantibodies characteristic of SLE, considerable effort was made to evaluate the possibility that these reactions were actually due to (Fig. 2) .
Several lines of evidence indicated that these immunologic reactions could not be attributed to DNA: anti-DNA or RNA: anti-RNA reactions. These include (a) the very low concentrations of DNA (< 5 isg/ml) and RNA ( 20 ,ug/ml) in undiluted suspensions of lysosomes containing 550-1,500 ;&g protein/ml; (b) the failure of high concentrations of demonstrably active DNase or RNase to affect either CF or precipitin reactions of lysosomes with SLE sera; (c) our ability to absorb anti-DNA antibody from an SLE serum without affecting its reactivity with lysosomes; and (d) the lack of correlation of anti-DNA and antilysosome reactions in individual sera.
Autoantibodies to other subcellular cytoplasmic organelles including mitochondria (8) (9) (10) (11) , microsomes (9, 10), ribosomes (12) (13) (14) , and soluble cytoplasmic antigens (15) have been identified by others in SLE sera. It appears unlikely that the reactions of our SLE sera with lysosomes are attributable to antimitochondrial antibodies because (a) mitochondrial structures were rare in our lysosome preparations by electron microscopy ( Fig. 1) , (b) neither succinic dehydrogenase nor reduced NAD dehydrogenase (cytochrome c reductase) activities were detected, and (c) the sedimentation characteristics of our lysosomal antigen are not typical of mitochondria (38) . Likewise, the RNase resistance and sedimentation properties of our lysosome antigen suggest that ribonucleoprotein, ribosomes, microsomes, or soluble cytoplasmic constituents are not the antigens responsible for the observed reactivity (see 9, 38, 39) . Our inability to detect (Na', K+)-ATPase in lysosomal membranes is evidence against major contamination by fragments of the leukocyte plasma membrane (25 (10, 16) .
The studies of these authors differ from ours in several respects. First, their published data are based largely on CF reactions of SLE sera with cytoplasmic fractions from rat and guinea pig liver and kidney. Secondly, CF activity was demonstrated by these workers using antigens at protein concentrations 12-20 times higher than in our (25 sg/ml) preparations. This might reflect the presence of a relatively large proportion of nonlysosome proteins in their admittedly crude (16) fractions, or a relative inefficiency of heterologous antigens in the CF assay.
The actual frequency of antilysosome antibodies in SLE may not be accurately reflected by the data in Table I and Fig. 2 . In many of the present cases serum from the most active or pretreatment phase of the illness was not available. The limited data in Table III suggest that corticosteroid therapy may effectively suppress such antibody.
In addition to the observations on antilysosome antibodies, evidence has been presented for the occurrence of lysosomal antigen in serum, synovial fluid, and pleural fluid of patients with SLE or other inflammatory diseases. This lysosomal antigen, which was identified by gel precipitin reactions with rabbit antiserum to human leukocyte lysosomes, appeared to be antigenically identical to a soluble component which can be released in vitro from intact lysosomes of normal donors. Since this component does not detectably react with SLE sera known to give precipitin or CF reactions with intact lysosomes, the naturally occurring lysosomal antigen appears to be either a distinct substance (e.g., a lysosomal enzyme rather than membrane antigen) or a membrane antigen in a degraded form.
The appearance of this lysosomal antigen in a variety of inflammatory fluids and in the serum of a non-SLE patient during a transient neutrophilic leukemoid reaction is consistent with its origin from granulocytes in vivo. Artifactual release of lysosomal antigen as a result of cell damage during collection of blood or fluids with high granulocyte counts was also considered. While this possibility cannot be dismissed, it seems unlikely in view of the uniform absence of the antigen in normals and its occurrence in SLE and RA patients with normal or reduced peripheral blood granulocytes. It is probable that a variety of subcellular antigens may be released at sites of tissue injury of different etiologies (40) . The presence of DNA (41, 42) and of lysosomal enzyme activities (43, 44) (16) , moreover, suggested that the autoantibody response to lysosomes may be a physiologic reaction to tissue injury. Yet, in the present studies, antibody to human lysosomes was not detected in sera of selected groups of patients with a variety of other rheumatic or autoimmune disorders except lupoid hepatitis (Table I) .
To date, we have not demonstrated in SLE sera the presence of the membrane-associated (sedimentable) lysosomal antigen with which the human antilysosome antibodies react. Such material may remain in inflamed tissues or be rapidly cleared from body fluids by phagocytes. It is conceivable that in SLE patients possessing circulating antibody to lysosomes, leukocyte breakdown at sites of inflammation could result in local formation and deposition of lysosome: antilysosome complexes with potential for perpetuation of tissue injury. The relationship, if any, of such antibodies in SLE patients to the other, soluble lysosomal antigen (i.e., that which is reactive with rabbit antiserum and antigenically similar to a nonsedimentable component released from intact granules) is not apparent at this time.
A final point of interest was the possible association of antilysosome antibody with leukopenia, thrombocytopenia, or Coombs-positive hemolytic anemia in SLE patients. In vitro studies had suggested that the membranes of lysosomes, leukocytes, and erythrocytes share certain antigenic determinants (45) (46) (47) (48) and that heterologous antilysosome antibody may injure intact granulocytes under experimental conditions (46) . Retrospective analysis of our patients' records did not demonstrate any of these associations, in agreement with the conclusion of Wiedermann and Miescher (10) .
